Hopefully not - they had $4.5m in the bank at the end of December. What I took from the half yearly report was that they had reduced overheads so income was closer to outgoings. If that is right and they continue to make sales like the recent ones then they should at least not be going backwards any more. Only time will tell if that is the case I guess. Ideally the negotiations to sell the Virolens inventory might free up more working capital but it is worth remembering the Board wrote that off entirely - again time will will tell whether that conservative judgement was necessary.
Hopefully not - they had $4.5m in the bank at the end of...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HCL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.86M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 13.5¢ | 13.5¢ | $35.87K | 265.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 86048 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 90761 | 3 |
View Market Depth
| Last trade - 15.54pm 21/06/2024 (20 minute delay) ? |
| HCL (ASX) Chart |